• Tweet
• Share
• Email this.

According to PMR forecasts, the pharmaceutical market in Poland will exceed PLN 31bn (approximately euro8bn) in 2011, growing by 4% compared with 2010. Generally we expect that the “years of plenty” for the pharmaceutical market are over and that this situation will last for a few years. The main reason is the anticipated cuts in public spending on reimbursed medicines, which constitute a substantial part of the market. Patients are likely to have to pay more, and not all will be able to afford the extra burden. Some will be forced to refrain from buying more expensive or less important medicines. In addition, we do not expect many new innovative drugs to be introduced into reimbursement lists, something that would support the sales of these expensive medicines.

Today’s economy requires businesses to keep close tabs on market activity in order to make sound decisions and maximise profits. If you are looking for the very latest and most viable data and analysis on the Polish pharmaceutical and healthcare market, you should read the latest PMR report Pharmaceutical and Healthcare Market in Poland 2011, Development Forecasts for 2011-2013.

This is a key report in PMR’s product portfolio, providing an overview of the pharmaceutical and healthcare market in Poland, its value and size in 2002-2010 and delivering market data and forecasts for 2011-2013.  The drug sector market is segmented by domestic and foreign, refunded and fully non-refundable, innovative and generic drugs, and by the 12 ATC categories.

The report also includes an analysis of the drug refund system in Poland and examines the most recent changes in drug reimbursement lists and those that came into force with the Reimbursement Act.  It analyses future revenue potential in the drug sector, as well as new market in dental care insurance and the provision of healthcare services to EU citizens outside their home countries, as part of the EU directive “Patients without borders” currently under discussion.

Pharmaceutical and Healthcare Market in Poland 2011, Development Forecasts for 2011-2013 combines valuable business intelligence from a variety of trusted sources into one clear, concise document – ready for delivery to you in a convenient electronic format.

About PMR

PMR Corporate is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR’s key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.